Press Releases

Press Releases

73% of Americans would like to see additional COVID-19 vaccines be available that are developed from a more traditional method 40% of parents whose children under age 18 are not yet vaccinated say they would be more likely to vaccinate their children if there was a new COVID-19 vaccine developed
February 15, 2022
MALVERN, Pa., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc .  (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that it will be participating in
January 6, 2022